Posted by Michael Wonder on 10 Jul 2017
A new treatment option for people with kidney cancer
10 July 2017 - People with advanced kidney cancer are set to benefit from a new treatment, after NICE has said cabozantinib should be available on the NHS.
NICE recommends cabozantinib as an option for people with advanced renal cell carcinoma.
The NICE appraisal committee were unable to recommend cabozantinib following their initial assessment of the drug in February 2017. This was because they felt some of the clinical evidence presented by the company was unreliable.
